...
【24h】

Radioprotection by copper and zinc complexes of 5-aminosalicylic acid: a preliminary study.

机译:5-氨基水杨酸的铜和锌配合物的辐射防护:初步研究。

获取原文
获取原文并翻译 | 示例
           

摘要

The effect of copper and zinc complexes of 5-aminosalicylic acid (hereafter referred to as Cu-5ASA and Zn-5ASA, respectively) against whole-body gamma radiation-induced cytotoxicity was studied in Swiss albino mice. Protection against lethal irradiation was evaluated from 30 day mouse survival (10 Gy) and endogenous spleen colony assay (11 Gy); and against sublethal dose (4 Gy) was assessed from gamma irradiation (RT)-induced formation of micronuclei in the mouse bone marrow 24 h postirradiation. Pretreatment with either Cu-5ASA (2.5-9 mg/kg) or Zn-5ASA (3.5-14 mg/kg) intraperitoneally (i.p.) delayed and reduced percentage mortality in mice exposed to 10 Gy RT. The doses 9 mg/kg for Cu-5ASA and 7 mg/kg for Zn-5ASA were found to be the most effective dose in preventing RT-induced weight loss and reducing percentage mortality. Both the drugs also caused an increase in the endogenous spleen colonies in mouse exposed to 11 Gy RT. At sublethal doses of RT, pretreatment with either Cu-5ASA or Zn-5ASA resulted in a significant decrease in the RT-induced micronucleated polychromatic erythrocytes and normochromatic erythrocytes (MPCEs and MNCEs) and an increase in the ratio of PCE to NCE (P/N), at 24 h postirradiation. These results show that both Cu-5ASA and Zn-5ASA are effective in protecting normal tissues against lethal and sublethal doses of RT. Further pretreatment with either Cu-5ASA or Zn-5ASA enhanced the survival of tumor-bearing mice (Ehrlich's ascites carcinoma) exposed to 7.5 Gy RT. In fact, both the complexes caused an increase in the mean and average survival times (MST and AST) when compared to the irradiated control, suggesting a synergetic effect of these drugs with radiation in causing cytotoxicity to the tumor cells. The data clearly indicate that both Cu-5ASA and Zn-5ASA significantly reduced the deleterious effect of radiation and hence could be useful agents in reducing the side effects of therapeutic radiation.
机译:在瑞士的白化病小鼠中研究了5-氨基水杨酸的铜和锌配合物(以下分别称为Cu-5ASA和Zn-5ASA)对全身γ辐射诱导的细胞毒性的影响。从小鼠30天存活率(10 Gy)和内源性脾脏集落试验(11 Gy)评估了对致命辐射的防护;照射后24小时,由γ射线(RT)诱导的小鼠骨髓中微核的形成来评估抗亚致死剂量(4 Gy)。腹膜内(i.p.)用Cu-5ASA(2.5-9 mg / kg)或Zn-5ASA(3.5-14 mg / kg)进行预处理可延迟并降低暴露于10 Gy RT的小鼠的死亡率。 Cu-5ASA的剂量为9 mg / kg,Zn-5ASA的剂量为7 mg / kg,是预防RT引起的体重减轻和降低死亡率的最有效剂量。两种药物还导致暴露于11 Gy RT的小鼠内源性脾脏集落增加。在亚致死剂量下,用Cu-5ASA或Zn-5ASA预处理可显着降低RT诱导的微核多色红细胞和正常色红细胞(MPCE和MNCE),并增加PCE与NCE的比例(P / N),照射后24小时。这些结果表明,Cu-5ASA和Zn-5ASA均可有效保护正常组织免受致命和亚致死剂量的RT的侵害。进一步用Cu-5ASA或Zn-5ASA进行预处理可以提高暴露于7.5 Gy RT的荷瘤小鼠(艾氏腹水癌)的存活率。实际上,与照射的对照相比,两种复合物均引起平均和平均存活时间(MST和AST)的增加,表明这些药物与放射的协同作用导致对肿瘤细胞的细胞毒性。数据清楚地表明,Cu-5ASA和Zn-5ASA均显着降低了辐射的有害作用,因此在减少治疗性辐射的副作用方面可能是有用的药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号